Clinical Trials in Salt Lake City

Showing 1961-1980 of 14,325 trials

One-Time DNA Study for Vasculitis

NCT01241305

The purpose of this study is to identify genes that increase the risk of developing vasculitis, a group of severe diseases that feature inflammation of blood vessels. Results of these studies will provide vasculitis researchers with insight into the causes of these diseases and generate new ideas for diagnostic tests and therapies, and will be of great interest to the larger communities of researchers investigating vasculitis and other autoimmune, inflammatory, and vascular diseases.

Eosinophilic Granulomatosis With Polyangiitis (Churg-Strauss)Giant Cell ArteritisGranulomatosis With Polyangiitis (Wegener's)+3 more

University of Pennsylvania1,000 participantsStarted Oct 2010

Los Angeles, California, United States • San Francisco, California, United States • Chicago, Illinois, United States +11 more locations

COMPLETEDPhase 3169 miles

A Study of Retatrutide (LY3437943) Once Weekly in Participants Who Have Obesity or Overweight and Osteoarthritis of the Knee

NCT05931367

The main purpose of this study is to evaluate the safety and efficacy of retatrutide once-weekly in participants who have obesity or are overweight and have osteoarthritis (OA) of the knee. The study will lasts about 77 weeks.

ObesityOverweightOsteo Arthritis Knee

Eli Lilly and Company445 participantsStarted Aug 2023

Phoenix, Arizona, United States • San Diego, California, United States • Waterbury, Connecticut, United States +46 more locations

One-Time DNA Study for Vasculitis

A Study of Retatrutide (LY3437943) Once Weekly in Participants Who Have Obesity or Overweight and Osteoarthritis of the Knee

Find Trials by Condition in Salt Lake City

Testing Whether the Addition of Carboplatin Chemotherapy to Cabazitaxel Chemotherapy Will Improve Outcomes Compared to Cabazitaxel Alone in People With Castrate-Resistant Prostate Cancer That Has Spread Beyond the Prostate to Other Parts of the Body

Fecal Microbiota Transplant National Registry

A Study of Neoadjuvant Atezolizumab Plus Chemotherapy Versus Placebo Plus Chemotherapy in Patients With Resectable Stage II, IIIA, or Select IIIB Non-Small Cell Lung Cancer (IMpower030)

A Study of TAK-500 With or Without Pembrolizumab in Adults With Select Locally Advanced or Metastatic Solid Tumors

Using Biomarker Tests to Select and Test New, Personalized Treatments for Extensive Stage Small Cell Lung Cancer, PRISM Study

Trial of DFP-10917 vs Non-Intensive or Intensive Reinduction for AML Patients in 2nd/3rd/4th Salvage

Assessment of Carpal Tunnel Syndrome by Shearwave Elastography

A Study of Revumenib and Mezigdomide in People With Leukemia

Therapeutic Effect of Cytoreductive Radical Prostatectomy in Men With Newly Diagnosed Metastatic Prostate Cancer

Study of GS-0151 in Participants With Rheumatoid Arthritis

A Study to Learn About a Vaccine Against E Coli in Healthy Adults

Combination of GNS561 and Trametinib in Patients With Advanced KRAS Mutated Cholangiocarcinoma

A Study to Test Whether Different Combinations of BI 765063, Ezabenlimab, Chemotherapy, Cetuximab, and BI 836880 Help People With Head and Neck Cancer or Liver Cancer

EXoPERT EMERALD Clinical Study

A Study of NTX-1472 in Social Anxiety Disorder

A Study to Investigate Improvement in Pruritus of Lichen Simplex Chronicus With Dupilumab Injections Compared With Placebo in Male and Female Participants Aged at Least 18 Years (STYLE 2)

Nivolumab + Docetaxel + ADT in mHSPC Patients With DDRD or Inflamed Tumors

Study to Evaluate the Efficacy and Safety of Lutathera in Patients With Grade 2 and Grade 3 Advanced GEP-NET